Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes

Life Sciences

Volumn 62, Issue 17-18, 1998, Pages 1701-1705

  Kawashima, K ^a   Fujii, T ^a   Watanabe, Y ^a   Misawa, H ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Acetylcholine; Choline acetyltransferase; Muscarinic receptor; Radioimmunoassay; T lymphocytes

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; MUSCARINIC RECEPTOR; PHYTOHEMAGGLUTININ; RECEPTOR SUBTYPE;

ANIMAL CELL; CHOLINERGIC TRANSMISSION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NEUROIMMUNOLOGY; NONHUMAN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ACETYLCHOLINE; ANIMALS; HUMANS; RADIOIMMUNOASSAY; RECEPTORS, MUSCARINIC; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0032571352     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00131-3     Document Type: Conference Paper

References (27)

1. 1. S. TUCEK, Handbook of Experimental Pharmacology (Vol. 86) The Cholinergic Synapse, V.P. WHITTAKER (ed), 125-165, Springer Verlag, Berlin (1988).
2. 2. W. MASLINSKI, Brain Behav. Immun. 3 1-14 (1989).
3. 3. I. RINNER and K. SCHAUENSTEIN, J. Neuroimmunol. 34 165-172 (1991).
4. 4. C. EVA, P. FERRERO, P. ROCCA, A. FUNARO, B. BERGAMASCO, L. RAVIZZA and E. GENAZZANI, Neuropharmacology 28 719-726 (1989).
5. 5. A.M. GENARO, G.A. CREMASCHI and E.S. BORDA, Immunopharmacology 26 21-29 (1993).
6. 6. P. COSTA, C.B. AUGER, D.J. TRAVER and L.G. COSTA, J. Immunopharmacol. 60 45-51 (1995).
7. 7. E. HELLSTROM-LINDAHL and A. NORDBERG, J. Neuroimmunol. 68 139-144 (1996).
8. 8. T. KANEDA, Y. KITAMURA, and Y. NOMURA, Mol. Pharmacol. 43 356-364 (1993).
9. 9. E.S. ARZT, S. FERNADEZ-CASTELO, A. DIAZ, S. FINKIESLMAN and V.E. NAHMOD, Int. J. Immunopharmacol. 11 275-281 (1989).
10. 10. P. MASTURZO, M. SALMONA, O. NORDSTROM, S. CONSOLO and H. LADINSKY, FEBS Lett. 192 194-198 (1985).
11. 11. T.B. STROM, M.A. LANE and K. GEORGE, J. Immunol. 127 705-710 (1981).
12. 12. J. KAPFHAMMER and C. BISCHOFF, Z. Physiol. Chem. 191 179-182 (1930).
13. 13. H.C. CHANG and J.H. GADDUM, J. Physiol. (Lond.) 79 255-285 (1933).
14. 14. G. DAMSMA and F. FLENTGE, J. Chromatogr. 428 1-8 (1988).
15. 15. H.W. DUDLEY, J. Physiol. (Lond.) 79 249-254 (1933).
16. 16. K. KAWASHIMA, H. ISHIKAWA and M. MOCHIZUKI, J. Pharmacol. Methods 3: 115-123 (1980).
17. 17. T. FUJII, S. YAMADA, N. YAMAGUCHI, K. FUJIMOTO, T. SUZUKI and K. KAWASHIMA, Neurosci. Lett. 201 207-210 (1995).
18. 18. T. FUJII, Y. MORI, T. TOMINAGA, I. HAYASAKA and K. KAWASHIMA, Neurosci. Lett. 227 21-24 (1997).
19. 19. K. KAWASHIMA, H. OOHATA, K. FUJIMOTO and T. SUZUKI, Neurosci. Lett. 80 339-342 (1987).
20. 20. K. KAWASHIMA, H. OOHATA, K. FUJIMOTO and T. SUZUKI, Neurosci. Lett. 104 336-339 (1989).
21. 21. K. KAWASHIMA, K. KAJIYAMA, K. FUJIMOTO, H. OOHATA and T. SUZUKI, Biog. Amine. 9 251-258 (1993).
22. 22. S. YAMADA, T. FUJII and K. KAWASHIMA, Neurosci. Lett. 225 25-28 (1997).
23. 23. I. RINNER and K. SCHAUENSTEIN, J. Neurosci. Res. 35 188-191 (1993).
24. 24. T. FUJII, T. TSUCHIYA, S. YAMADA, K. FUJIMOTO, T. SUZUKI, T. KASAHARA and K. KAWASHIMA, J. Neurosci. Res. 44 66-72 (1996).
25. 25. S. TUCEK, J. Physiol. (Lond.) 322 53-69 (1982).
26. 26. T. FUJII, S. YAMADA, H. MISAWA, S. TAJIMA, K. FUJIMOTO, T. SUZUKI and K. KAWASHIMA, Proc. Japan. Acad. 71B 231-235 (1995).
27. 27. B.J. IMBODEN, M.D. SHOBACK, G. PATTISON and D.J. STOBO, Proc. Natl. Acad. Sci. U.S.A. 83 5673-5677 (1986).